Pharmaceutical manufacturing is the most regulated industrial slip-testing brief in the UK — GMP cleanroom protocols, MHRA inspections, and the cumulative impact of validated-cleaning chemistry on resin floor coatings combine to make documented PTV management a core part of the Q…
Tier 1 · Process Industries
Every pharmaceutical manufacturing site has a distinct surface vocabulary that drives the testing protocol. We test the actual surfaces present, not a generic baseline.
Seamless polyurethane and epoxy resin cleanroom floorsthe dominant GMP-validated finish, with PTV strongly affected by validated cleaning chemistry
PVC sheet welded floors in lower-grade cleanroom zonestested independently
Anti-static and ESD-controlled flooring in solid-dose tablet-pressing hallsESD specification
Cementitious polyurethane in API handling zoneschemical-resistant
Stainless steel platform tread at vessel accesstested independently
Cleanroom airlock transition floorstested independently of parent zone
Generic slip testing misses the zones that actually generate incidents. Pharmaceutical Manufacturing sites have distinct high-risk zones that warrant independent testing.
Operatives changing PPE in airlocks track residual cleaning solution from the high-grade zone into the lower-grade zone — PTV at airlock thresholds drops measurably during shift cycles.
Repeated validated cleaning with hypochlorite, hydrogen peroxide, or quaternary ammonium chemistry slowly degrades resin topcoats — PTV trends over a 12-month cycle can identify topcoat replacement timing.
Active ingredient handling areas combine fine-particulate slip risk with strict containment requirements — PTV testing must comply with airborne-containment protocols.
The route from goods-in to GMP storage carries external contamination — PTV at the warehouse-to-GMP threshold is a defined regulatory documentation point.
Pharmaceutical slip testing supports MHRA GMP compliance under the Orange Guide / EudraLex Volume 4. While GMP doesn't specify PTV directly, the requirement to demonstrate that floors do not present an operational hazard means documented UKAS ISO/IEC 17025 PTV evidence is increasingly expected at MHRA inspections. HSE INDG225 and Workplace Regulations 1992 Reg 12 apply alongside. Reports must integrate with the customer's QMS documentation framework.
An MHRA-licensed solid-dose pharmaceutical manufacturer commissioned twice-yearly UKAS pendulum testing across Grade C and Grade D cleanroom zones, the API receiving area, and the goods-out warehouse. Testing is performed during scheduled cleanroom shutdowns and reports are formatted for direct attachment to the customer's QMS as controlled documents. The customer's MHRA inspector cited the documentation as best practice during a routine inspection.
Whether you operate a single industrial site, a multi-site portfolio, or an FM contractor brief covering multiple operators, we'll return a fully-costed, no-obligation quotation within one working day.
Mon–Fri, 8am–6pm office hours.
23:00–05:00 attendance for production-floor sites by arrangement.